EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen Access · CC BY 4.0

Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery

Michele Figus, Fabrizio Giansanti, Edoardo Villani, Jorge L Alió, Ladislav Jančo, Stefano Mercuri iD, Stefano Camnasio, Carlo Cagini iD

Journal of Ocular Pharmacology and Therapeutics · 01.03.2024 · 40 (2) · 117-125

DOI: 10.1089/jop.2023.0096 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, online erschienen am 14.03.2024. Verfasst von Michele Figus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Cataract Extraction, Phacoemulsification, Cataract. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare the efficacy and safety of a novel ophthalmic anesthetic, chloroprocaine 3% gel to tetracaine 0.5% eye drops in patients undergoing cataract surgery with phacoemulsification.

Methods

This was a prospective, randomized, multicenter, active-controlled, masked-observer, parallel group competitive equivalence study. The study comprised 338 patients having routine cataract extraction by clear corneal phacoemulsification, randomized to receive 3 drops of chloroprocaine gel ( n = 166) or tetracaine eye drops ( n = 172) before surgery. The primary objective of the study was to assess the equivalence of chloroprocaine gel to tetracaine eye drops as proportion of patients with successful ocular surface anesthesia, without any supplementation just before intraocular lens implantation. Safety measurements were pain, irritation, burning, stinging, photophobia, and foreign body sensation, graded by the patient and objective ocular signs.

Results

Equivalence was demonstrated, with a somewhat higher success rate of chloroprocaine gel: 152/166 (92.0%) chloroprocaine versus 153/172 (90.5%) tetracaine patients achieved ocular surface anesthesia with no supplementation. Difference in proportions was 1.5% confidence interval [95% CI: (−3.6 to 6.6)] and 90% CI fell within (−10 to 10). Mean onset of anesthesia was 1.35 ± 0.87 min for chloroprocaine and 1.57 ± 1.85 for tetracaine ( P = 0.083). Mean duration of anesthesia was 21.57 ± 12.26 min for chloroprocaine and 22.04 ± 12.58 for tetracaine ( P = 0.574). No treatment emergent adverse events related to chloroprocaine were reported and no relevant findings related to local tolerance or vital signs were observed in both arms.

Conclusions

Results obtained from the present cataract study demonstrated that chloroprocaine 3% ophthalmic gel is safe and effective, representing a valid alternative in ocular topical anesthesia. Clinical Trial Registration number: NCT04685538.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cataract ExtractionPhacoemulsificationCataractHumansAnesthetics, LocalTetracaineProspective StudiesLidocainePain MeasurementAnesthesia, LocalPainOphthalmic SolutionsProcaine

Stichwörter der Autor:innen

cataract surgerychloroprocaineocular proceduretopical ocular anesthesia

Substanzen

Anesthetics, LocalTetracainechloroprocaineLidocaineOphthalmic SolutionsProcaine

Autor:innen und Institutionen

  • Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
  • Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
  • Eye Clinica, San Giuseppe Hospital, IRCCS Multimedica Milano, Milan, Italy.
  • Opthalmology Department, Vissum Miranza Alicante, Alicante, Spain.
  • Očná klinika SZU Nám., F.D.Roosevelt Hospital, Banská Bystrica, Slovakia.
  • Scientific Department, Sintetica SA, Mendrisio, Switzerland.

ORCID-Profile: Stefano Mercuri, Carlo Cagini

Zitieren

APA

Figus, M., Giansanti, F., Villani, E., Alió, J. L., Jančo, L., Mercuri, S., Camnasio, S., & Cagini, C. (2024). Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery. Journal of Ocular Pharmacology and Therapeutics, 40(2), 117-125. https://doi.org/10.1089/jop.2023.0096

Vancouver

Figus M, Giansanti F, Villani E, Alió JL, Jančo L, Mercuri S, et al. Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery. Journal of Ocular Pharmacology and Therapeutics. 2024;40(2):117-125. doi:10.1089/jop.2023.0096

BibTeX
@article{Figus2024,
  author = {Figus, Michele and Giansanti, Fabrizio and Villani, Edoardo and Alió, Jorge L and Jančo, Ladislav and Mercuri, Stefano and Camnasio, Stefano and Cagini, Carlo},
  title = {Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery},
  journal = {Journal of Ocular Pharmacology and Therapeutics},
  year = {2024},
  volume = {40},
  number = {2},
  pages = {117--125},
  doi = {10.1089/jop.2023.0096}
}
Kostenlos starten →